"Parvovirus B19-related Acute Hepatitis: Clinical Spectrum and Outcome in Children"
- PMID: 39473446
- PMCID: PMC11513682
- DOI: 10.1016/j.jceh.2024.102416
"Parvovirus B19-related Acute Hepatitis: Clinical Spectrum and Outcome in Children"
Abstract
Background/aims: Acute liver injury is a common manifestation of parvovirus B19 (PVB19) infection in immunocompromised patients. However, literature in immunocompetent children is scarce. We aimed to study the clinicolaboratory features and outcome of hepatic involvement by PVB19 infection in hospitalized children.
Methods: We retrospectively analyzed our prospectively kept database of all children (<18 years old) admitted with acute viral hepatitis (AVH), acute liver failure (ALF) or acute-on-chronic liver failure (ACLF), and PVB19 infection between January 2010 and December 2023. Clinical features, laboratory parameters, and complications were evaluated. Poor outcome was defined as death or liver transplantation.
Results: A total of 35 children (19 boys [54%], median age: 7.25 [interquartile range: 4-10.8] years) with PVB19-related hepatitis were studied (28 [80%] isolated PVB19 infection and 7 [20%] coinfections [3 with Epstein-Barr virus, 2 with hepatitis A, and 1 each with hepatitis-E and cytomegalovirus]). AVH (17, 49%) was the most common presentation, followed by ALF (13, 37%) and acute insult in ACLF (5, 14%). Patients with coinfection had significantly higher bilirubin (14.6 [9.4-21.5] vs 6.8 [4.3-10.9] mg/dl; P=0.004) and transaminases (ALT: 697 [428-1296] vs. 277 [157-478] U/L; P=0.02) but similar mortality (1/7 vs 6/23; P=1.0) than PVB19 alone. Nine cases (25.7%) had extrahepatic complications (hemophagocytic lymphohistiocytosis [HLH]: 3, acute kidney injury: 3, aplastic anemia: 2, and myocarditis: 1). Poor outcome occurred in 38% (5/13) ALF, 11.7% (2/17) AVH (HLH: 1, myocarditis: 1), and none (0/5) of the ACLF cases.
Conclusion: PVB19 should be considered in children presenting with indeterminate acute liver injury, especially in younger children or those with complications such as aplastic anemia, HLH, or myocarditis.
Keywords: aplastic anemia; children; hemophagocytic lymphohistiocytosis; hepatitis; parvovirus B19.
© 2024 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280. Health Technol Assess. 2006. PMID: 16904047
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
High specificity electrocardiogram patterns for parvovirus B19 myocarditis in children: bridging electrocardiogram findings to aetiological diagnosis.Cardiol Young. 2025 May;35(5):1023-1027. doi: 10.1017/S1047951125001878. Epub 2025 May 8. Cardiol Young. 2025. PMID: 40337792
-
Viral Myocarditis as a Factor Leading to the Development of Heart Failure Symptoms, Including the Role of Parvovirus B19 Infection-Systematic Review.Int J Mol Sci. 2024 Jul 25;25(15):8127. doi: 10.3390/ijms25158127. Int J Mol Sci. 2024. PMID: 39125696 Free PMC article.
-
Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.Cochrane Database Syst Rev. 2017 Mar 21;3(3):CD011645. doi: 10.1002/14651858.CD011645.pub2. Cochrane Database Syst Rev. 2017. PMID: 28321877 Free PMC article.
Cited by
-
Retrospective and Prospective Surveillance and Clinical Presentation of Parvovirus B19 in Veneto, Italy, 2024.Microorganisms. 2025 Feb 16;13(2):430. doi: 10.3390/microorganisms13020430. Microorganisms. 2025. PMID: 40005795 Free PMC article.
References
-
- Brown K.E., Young N.S. The simian parvoviruses. Rev Med Virol. 1997;7:211–218. - PubMed
-
- Young N.S., Brown K.E. Mechanisms of disease: PVB19. N Engl J Med. 2004;350:586–597. - PubMed
-
- Chorba T., Coccia P., Holman R.C. The role of PVB19 in aplastic crisis and erythema infectiosum (fifth disease) JID (J Infect Dis) 1986;154:383–393. - PubMed
-
- Broliden K., Tolfvenstam T., Norbeck O. Clinical aspects of PVB19 infection. J Intern Med. 2006;260:285–304. - PubMed
LinkOut - more resources
Full Text Sources